免疫应答概论课件-2_第1页
免疫应答概论课件-2_第2页
免疫应答概论课件-2_第3页
免疫应答概论课件-2_第4页
免疫应答概论课件-2_第5页
已阅读5页,还剩17页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、The Immune SystemInnateAntimicrobial PeptidesPhagocytes (Macrophages, PMNs, Monocytes, DCs)Alternative Complement SystemAcquired (Adaptive)-B Lymphocytes Antibody-T Lymphocytes Cytotoxicity “Help” Antibody Cytokine SecretionBDCThe Immune SystemInnateAcquire2 light chains ( or )2 heavy chains (5 isot

2、ypes: IgG, M, A, D, E)2 Binding sites (Divalent)Secreted into circulationBinds Soluble Antigen2 Chains / (95%) or / (5%)1 Binding site (Monovalent)Membrane Bound, Not SecretedBinds Antigen Complexed with MHCZap 70fynlckgezVVCCCH1CH2CH3CH2CH3CH1CLCLVLVLVHVHedzIga/IgbIga/IgbBlk, Fyn or LynB and T Lymp

3、hocyte Antigen ReceptorsBDC2 light chains ( or )2 ChainXPID: X-linked polyendocrinopathy, immune dysfunction and diarrheaXLAAD: “Autoimmunity Allergic Dysreg”Scurfin gene (Foxp3/JM2)Immunopathogenesis: Th2 Cytokines, abnormal activation (Il-4,5,13)-Scurfy+Nude: No Autoimmunity-CD4+ into Nude: Diseas

4、e-Bone Marrow into irradiated: No Disease-Require Antigen Stimulation for Disease-Mixed Chimera: No DiseaseBDCXPID: X-linked polyendocrinopaHuman Leukocyte Antigenhuman MHCcell-surface proteinsimportant in self vs. nonself distinctionpresent peptide antigens to T cellsCLASS I: A,B,CCLASS II: DR,DQ,D

5、PHLAJ. NobleHuman Leukocyte AntigenCLASS IThe Human Leukocyte Antigen Complex (6p21.31)DP DQ DR B C AClass II (1.1 Mb)Class IIIClass I (2.2Mb)Complement and CytokinesClass I-like genesand pseudogenesFrequent Recombination Recombinationis RareTelomereCentromere Recombinationis Rare(0.7Mb)BDCThe Human

6、 Leukocyte Antigen Coa3b2a1a2a1a2b1b2Binds 8-10mersExpressed on most Nucleated cellsPresents Cytosolic Proteins to CD8+ T cellsBinds 13-25mersExpressed on APCs, Macs, B cells, activated T cellsPresents Vesicular Proteins to CD4+ T cellsClass IClass IIHLA Class I and II Molecules Have a Distinct Stru

7、cture and FunctionBDCa3b2a1a2a1a2b1b2Binds 8-10mers0501 02010301 0302 ciscisDQA1 DQB1transDQA1*0301/DQB1*0201DQA1*0501/DQB1*0302DQA1*0501/DQB1*0201DQA1*0301/DQB1*0302MaternalPaternalCis and Trans- Class II DimerizationBDC0501 0201030DQB1*0402Asp57Leu56 -chain-chainBDCBDCDQB1*0402Asp57Leu56 -chainHLA

8、-Peptide: TCRCDR1CDR2CDR3CDR3CDR2CDR1NH3+COO-TCRalphaTCRbeta2 Helix1 HelixBDCHLA-Peptide: TCRCDR1CDR2CDR3CDCo-Stimulation TCellAPCCTLA-4 -CD28 +CD154(CD40L)CD2CD58CD40B7(+)IL-1, IL-6, TNFIL-10TGF(-)TCR-MHCBDCCo-Stimulation TAPCCTLA-4 -CAbsence of Signal 2ActivationClonal Anergy or DeletionTCRMHCAPCT

9、oleranceT CellTCRMHCAPCSignal 1 + Signal 2B7T CellcytokinesCD28The 2-Signal Model of Lymphocyte ActivationBDCAbsence of Signal 2ActivationCMHC/self-peptideCD4MHC/VbCD4CD4+ Vbx T cell APCActivated autoreactive CD4+TCR Vbx TH1 cell TCR VbxTCR Vbx(1) expansion of CD4+, autoreactive TH1 cells specific f

10、or autoantigens(2) migration and infiltration of these self reactive CD4+ TH1 cells into tissues and induction of inflammation and autoimmunity(3) induction of regulatory cells which control the growth and activation of the pathogenic autoreactive repertoire of CD4+ T cellsInduction of CD4+ TH1 medi

11、ated autoimmunity:A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetesL. Chess 2002MHC/self-peptideCD4MHC/VbCD4CDTH1 CD4+ cellsTH2 CD4+ cells CD8 or CD4 suppressor precursorCD8 or CD4 suppressor effectorActivated CD4 T cellspeptide/APC Regulatory immunityCD

12、4/CD8 interactions(- )(- )The Control of Activated CD4+ T Cells by Regulatory T cellsApoptosisResting CD4 T cellsIL-12/IFN-gIL-4NKT cells/ CD4+CD25+ cellsCD4+CD25- cells(- )(- )IL-10IFN-gL. Chess 2002TH1 CD4+ cellsTH2 CD4+ cells CT cell activation is regulated by signals derived from the TCR /CD3/CD

13、4 complex and the CD40L and CD28/CTLA-4 co-stimulatory molecules gedzzCD3MHC class II a,b TCRhhPeptide antigenCD4+ T Cell Antigen Presenting Cell (APC)VaVbCaCbCD4Antigen specific TCR signalsCD40CD40LsignalCD28/CTLA-4CD80 (B7.1)/CD86 (B7.2)lckCo-stimulatory signals(- ) / +L. Chess 2002T cell activati

14、on is regulatedgedVaCaCbVbzzp56 lck peptideCD3CD28CD40LFA-3LFA-1ICAM-1MHC IIB7CD40LCD4CD45TCRCD2CD4+ T CellAPC/ B cellhhMolecular Interactions of Helper T Cells and APCB7CTLA-4VLA-1CollagenCD80/CD86L. Chess 2002gedVaCaCbVbzzp56 lck peptidMHC/peptideTCRQa-1/VbActivated CD4+ T cellRestingCD4+ T cellDo

15、wn-regulation of Activated CD4+ T CellsT cell activation induces expression of functional T cell surface molecules Regulatory CD8+ T cellTCR (anti-Qa-1/Vb) Activated CD8+ T cell(+)(-)TCRAPCTCRLate Activated CD4+ T cellVLA-1CollagenCD40LMigration of sites of inflammationInduction and activation of B

16、cells APCsCD25L. Chess 2002MHC/peptideTCRQa-1/VbActivatedActivated TH1 CD4+ T CellCD4+ Cell(TH2 )CD4+ Cell(TH0 )DR3, DR4,DQ8/insulin peptide CD2Macrophage/dendritic cellFc R IFN-g IL-12CD40LCD40a,b, TCRIL-1, TNF, LT, NO, PGE-2B Cell?anti-insulin, GAD ab anti-MogIL-4Immunopathophysiology of Diabetes?

17、Antibody mediated injuryDendritic cell/APCCD40LIL-4CD40LCD8+ CTLFasLperforinb cell deathb islet cellsL. Chess 2002Activated TH1 CD4+ T CellCD4+ Innate Immune System: Toll-like receptor activation of APC T CellCD28B7TCR-MHCLPSToll Like Receptor(pattern Recognition R)IL-1,6,12“Signal 3”Signal 2Signal

18、1Anitgen Presenting Cell (APC)BDCInnate Immune System: Toll-likTh1 vs. Th2 CD4 T CellsTh1IL-12 for differentiationCytokines:Interferon-Interleukin-2Intracellular Pathogens CD8 CytotoxicityDelayed Type HypersensitivityMacrophage ActivationTh2IL-4 for differentiationCytokines:Inerluekin-4Interleukin-5Interluekin-13Extracellular PathogensB Cell activation & IgEImmunoglobu

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论